Participation of serotonergic mechanisms in the pathophysiology of experimental neoplastic spinal cord compressionSIEGAL, T; SIEGAL, T.SIEGAL, T; SIEGAL, T.Neurology. 1991, Vol 41, Num 4, pp 574-580, issn 0028-3878Article

Current considerations in the management of neoplastic spinal cord compressionSIEGAL, T; SIEGAL, T.SIEGAL, T; SIEGAL, T.Spine (Philadelphia, PA. 1976). 1989, Vol 14, Num 2, pp 223-228, issn 0362-2436Article

Treatment of malignant epidural cord and cauda equina compressionSIEGAL, T; SIEGAL, T.SIEGAL, T; SIEGAL, T.Progress in experimental tumor research. 1985, Vol 29, pp 225-234, issn 0079-6263Article

Serotonergic manipulations in experimental neoplastic spinal cord compressionSIEGAL, T; SIEGAL, T.SIEGAL, T; SIEGAL, T.Journal of neurosurgery. 1993, Vol 78, Num 6, pp 929-937, issn 0022-3085Article

Surgical decompression of anterior and posterior malignant epidural tumors compressing the spinal cord: a prospective studySIEGAL, T; SIEGAL, T.SIEGAL, T; SIEGAL, T.Neurosurgery. 1985, Vol 17, Num 3, pp 424-432, issn 0148-396XArticle

OSTEOTOMY OF THE HIP IN CHILDREN: POSTERIOR APPROACHROOT L; SIEGAL T.1980; J. BONE JOINT SURG., AMER. ED.; USA; DA. 1980; VOL. 64; NO 2; PP. 571-575; BIBL. 5 REF.Article

ANTERIOR DECOMPRESSION OF THE SPINE FOR METASTATIC EPIDURAL CORD COMPRESSION: A PROMISING AVENUE OF THERAPY.SIEGAL T; SIEGAL T; SIEGAL T; SIEGAL T; ROBIN G et al.1982; ANN. NEUROL.; ISSN 0364-5134; USA; DA. 1982; VOL. 11; NO 1; PP. 28-34; BIBL. 19 REF.Article

CNS involvement by non-Hodgkin's lymphoma. Response to a standard therapeutic protocolRAZ, I; SIEGAL, T; SIEGAL, T et al.SIEGAL, T; SIEGAL, T et al.Archives of neurology (Chicago). 1984, Vol 41, Num 11, pp 1167-1171, issn 0003-9942Article

PERIODIC ATAXIA: AN UNUSUAL NON-FAMILIAL VARIATION WITH PAROXYSMAL EEG FEATURESBRAHAM J; SIEGAL T; SADEH M et al.1982; J. NEUROL.; DEU; DA. 1982; VOL. 227; NO 1; PP. 55-59; ABS. GER; BIBL. 7 REF.Article

Experimental neoplastic spinal cord compression : effect of anti-inflammatory agents and glutamate receptor antagonists on vascular permeability. CommentSIEGAL, T; SIEGAL, T; SIEGAL, T; SIEGAL, T; LOSSOS, F et al.Neurosurgery. 1990, Vol 26, Num 6, pp 967-970, issn 0148-396X, 4 p.Article

Leptomeningeal metastases: peripheral nerve and root involvement, clinical and electrophysiological studyARGOV, Z; SIEGAL, T.Annals of neurology. 1985, Vol 17, Num 6, pp 593-596, issn 0364-5134Article

A PLIABLE AND UNOBTRUSIVE VASCULAR CLAMPING DEVICE.SIEGAL T; ADAR R; KATZENELSON A et al.1977; SURG. GYNECOL. OBSTETR.; U.S.A.; DA. 1977; VOL. 144; NO 5; PP. 764-765Article

Electric shock-like sensations in 42 cancers patients : clinical characteristics and distinct etiologiesLOSSOS, A; SIEGAL, T.Journal of neuro-oncology. 1996, Vol 29, Num 2, pp 175-181, issn 0167-594XArticle

Spinal subarachnoid hermorrhage associated with leptomeningeal metastasesLOSSOS, A; SIEGAL, T.Journal of neuro-oncology. 1992, Vol 12, Num 2, pp 167-171, issn 0167-594XArticle

Numb chin syndrome in cancer patients : etiology, response to treatment, and prognostic significanceLOSSOS, A; SIEGAL, T.Neurology. 1992, Vol 42, Num 6, pp 1181-1184, issn 0028-3878Article

METHOTREXATE TREATMENT IN DERMATOMYOSITISSAROVA PINHAS I; SIEGAL T; TURGMAN J et al.1977; EUROP. NEUROL.; CHE; DA. 1977; VOL. 16; NO 1-6; PP. 149-154; BIBL. 12 REF.Article

Maculopathy in patients with primary CNS lymphoma treated with chemotherapy in conjunction with blood-brain barrier disruptionVICUNA-KOJCHEN, J; FRENKEL, S; SIEGAL, T et al.British journal of ophthalmology. 2008, Vol 92, Num 2, pp 231-235, issn 0007-1161, 5 p.Article

Leptomeningeal metastases : Rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?SIEGAL, T.Journal of neuro-oncology. 1998, Vol 38, Num 2-3, pp 151-157, issn 0167-594XConference Paper

Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model : biodistribution and therapeutic efficacySIEGAL, T; HOROWITZ, A; GABIZON, A et al.Journal of neurosurgery. 1995, Vol 83, Num 6, pp 1029-1037, issn 0022-3085Article

Leptomeningeal metastases ― treatment results in 98 consecutive patientsPFEFFER, M. R; WYGODA, M; SIEGAL, T et al.Israel journal of medical sciences. 1988, Vol 24, Num 9-10, pp 611-618, issn 0021-2180Article

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumorsDOOLITTLE, N. D; MINER, M. E; NIXON, R et al.Cancer. 2000, Vol 88, Num 3, pp 637-647, issn 0008-543XArticle

Effect of a chemical delivery system for dexamethasone (Dex-CDS) on peritumoral edema in an experimental brain tumor modelSIEGAL, T; SOTI, F; BIEGON, A et al.Pharmaceutical research. 1997, Vol 14, Num 5, pp 672-675, issn 0724-8741Article

Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumorsSIEGAL, T; RUBINSTEIN, R; TZUK-SHINA, T et al.Journal of neurosurgery. 1997, Vol 86, Num 1, pp 22-27, issn 0022-3085Article

Clinical significance of diffuse dural enhancement detected by magnetic resonance imagingRIVER, Y; SCHWARTZ, A; GOMORI, J. M et al.Journal of neurosurgery. 1996, Vol 85, Num 5, pp 777-783, issn 0022-3085Article

Leptomeningeal metastases : analysis of 31 patients with sustained off-therapy response following combined-modality therapySIEGAL, T; LOSSOS, A; PFEFFER, M. R et al.Neurology. 1994, Vol 44, Num 8, pp 1463-1469, issn 0028-3878Article